Print

CUTHIVAC002

Phase I Clinical Trial to Assess the Safety and Immunogenicity of HIV DNA-C CN54ENV Immunisations Administered Via the Intramuscular and Intradermal Methods With and Without Electroporation Followed by Boosting With Recombinant HIV CN54gp140 in Healthy Male and Female Volunteers

Trial Details:

I Ongoing
Imperial College London November 02, 2015
DNA-C CN54ENV ,CN54gp140 DNA-C CN54ENV : DNA plasmid containing the Clade C gp140 envelope gene from HIV-1 isolate CN54
DNA-C CN54ENV DNA
CN54gp140 Protein
United Kingdom 24
NCT02589795
https://clinicaltrials.gov/show/NCT02589795